2020
DOI: 10.1093/cid/ciaa1086
View full text
|
|
Share

Abstract: Abstract Patients with autoantibodies to IFN-γ may develop severe nontuberculous mycobacterial infections. We describe the novel use of daratumumab in a patient with autoantibodies to IFN-γ who had progressive infection, resulting in clinical and radiographic improvement.

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

0
4
0

Publication Types

Select...

Relationship

0
0

Authors

Journals